PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32726604-0 2020 Isoliquiritigenin protects against angiotensin II-induced fibrogenesis by inhibiting NF-kappaB/PPARgamma inflammatory pathway in human Tenon"s capsule fibroblasts. isoliquiritigenin 0-17 angiotensinogen Homo sapiens 35-49 32726604-1 2020 PURPOSE: To examine the protective effects of Isoliquiritigenin (ISL) in angiotensin II (ANG II)-induced inflammation and fibrosis on Human Tenon"s capsule Fibroblasts (HTFs) and Mouse Peritoneal Macrophages (MPMs). isoliquiritigenin 46-63 angiotensinogen Homo sapiens 73-87 32726604-1 2020 PURPOSE: To examine the protective effects of Isoliquiritigenin (ISL) in angiotensin II (ANG II)-induced inflammation and fibrosis on Human Tenon"s capsule Fibroblasts (HTFs) and Mouse Peritoneal Macrophages (MPMs). isoliquiritigenin 65-68 angiotensinogen Homo sapiens 73-87 32726604-1 2020 PURPOSE: To examine the protective effects of Isoliquiritigenin (ISL) in angiotensin II (ANG II)-induced inflammation and fibrosis on Human Tenon"s capsule Fibroblasts (HTFs) and Mouse Peritoneal Macrophages (MPMs). isoliquiritigenin 65-68 angiotensinogen Homo sapiens 89-95 30340829-0 2018 Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-kappaB pathways. isoliquiritigenin 0-17 angiotensinogen Homo sapiens 33-39 34655849-11 2021 Furthermore, drug response analysis implied that AGT expression was associated with isoliquiritigenins (ISL). isoliquiritigenin 84-102 angiotensinogen Homo sapiens 49-52 34655849-11 2021 Furthermore, drug response analysis implied that AGT expression was associated with isoliquiritigenins (ISL). isoliquiritigenin 104-107 angiotensinogen Homo sapiens 49-52